Experimental cardiac fibrosis: Differential time course of responses to mineralocorticoid-salt administration

Endocrinology

Volumn 142, Issue 8, 2001, Pages 3625-3631

  Fujisawa, Genro ^a   Dilley, Rodney ^a   Fullerton, Meryl J ^a   Funder, John W ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3; DEOXYCORTICOSTERONE; MINERALOCORTICOID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIET; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR; UNINEPHRECTOMY;

EID: 0034920217     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.8.8339     Document Type: Article

References (29)

1. Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro
2. Functional implications of brain corticosteroid receptor diversity
3. Myocardial fibrosis and elevations in arterial hypertension
4. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells
5. Role of 11β-hydroxysteroid dehydrogenase on nongenomic aldosterone effects in human arteries
6. Relationship of plasma aldadiene levels and antimineralocorticoid effects of spironolactone in the laboratory
7. Epithelial sodium channel regulated by aldosterone-induced protein
8. + channels
9. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension
10. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats
11. Myocardial fibrosis associated with aldosterone or angiotensin II administration: Attenuation by calcium channel blockade
12. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone
13. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension
14. Mineralocorticoids, hypertension and cardiac fibrosis
15. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion
16. In vivo left ventricular function and collagen expression in aldosterone/salt-induced hypertension
17. Effects of desoxycorticosterone acetate (DOCA) plus saline drinking on gentamicin-mediated nephropathy in rats
18. Reversal of cardiac fibrosis in DOCA-salt hypertensive rats by inhibition of the renin angtiotensin system
19. Anti-fibrotic effects of spironolac tone in preventing myocardial fibrosis in systemic arterial hypertension
20. Inhibition of angiotensin converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II
21. Determinants of cardiac fibrosis in experimental hypermeniralocorticoid states
22. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity
23. 16βHydroxydehydroepiandrosterone: The dichotomy between renal receptor binding and urine electrolyte activity
24. Prerequisite for aldosteorne action. Mineralocorticoid receptor and 11βhydroxysteroid dehydrogenase in human heart
25. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis
26. + pump activation during short-term exposure of myocytes to aldosterone
27. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells
28. Aldosterone-receptor deficiency in pseudohypoaldosteronism
29. Cloning of human mineralocorticoid receptor cDNA: Structural and functional kinship with the glucocorticoid receptor